z-logo
open-access-imgOpen Access
Progestin-Primed Ovarian Stimulation is a non-inferior alternative to the GnRH Antagonist Protocol in patients undergoing assisted reproductive techniques: a retrospective study
Author(s) -
João Pedro Junqueira Caetano,
Luciana Campomizzi Calazans,
Leci Veiga Caetano Amorim,
Leonardo Matheus Ribeiro Pereira,
Erica Becker Sousa Xavier,
Arlene Campos,
Bruna Barbosa Coimbra,
Ricardo Mello Marinho
Publication year - 2022
Publication title -
jbra
Language(s) - English
Resource type - Journals
eISSN - 1518-0557
pISSN - 1517-5693
DOI - 10.5935/1518-0557.20210057
Subject(s) - progestin , medicine , antagonist , gonadotropin releasing hormone antagonist , ovulation , pregnancy rate , hormone antagonist , blastocyst , ovulation induction , pregnancy , gynecology , andrology , gonadotropin releasing hormone , endocrinology , hormone , luteinizing hormone , biology , embryo , receptor , embryogenesis , genetics , microbiology and biotechnology
To demonstrate the non-inferiority of Clinical Pregnancy Rates from Progestin-Primed Ovarian Stimulation compared to the GnRH Antagonist Protocol when the freeze-all and blastocyst transfer strategy is applied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here